Back
Rapid7, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Buy
55
RPD
Rapid7, Inc.
Last Price:
$16.36
Seasonality Move:
6.94%
Buy
77
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.65
Seasonality Move:
9.28%
Buy
55
Rapid7, Inc. (RPD)
is a Buy
Is Rapid7, Inc. a Buy, Sell or Hold?
-
The current Rapid7, Inc. [RPD] share price is $16.36. The Score for RPD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
RPD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.65. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RPD Stock Price Chart
What is Rapid7, Inc.'s stock price today?
-
The Rapid7, Inc. share price today is $16.36The current trend is relatively stagnant and RPD is experiencing slight selling pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
RPD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 56.22 | Buy |
| Chaikin Money Flow: | -387955 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 21.57 | Buy |
| Relative Strength Index (14 RSI): | 86.06 | Buy |
| Chaikin Money Flow: | 367727 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RPD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.12 | Buy |
| 20-day SMA: | 15.05 | Buy |
| 50-day SMA: | 16.65 | Sell |
| 200-day SMA: | 21.64 | Sell |
| 8-day EMA: | 16.08 | Buy |
| 20-day EMA: | 15.74 | Buy |
| 50-day EMA: | 16.61 | Sell |
| 200-day EMA: | 22.41 | Sell |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.33 | Buy |
| 20-day SMA: | 219.69 | Buy |
| 50-day SMA: | 150.04 | Buy |
| 200-day SMA: | 68.84 | Buy |
| 8-day EMA: | 219.45 | Buy |
| 20-day EMA: | 204.15 | Buy |
| 50-day EMA: | 162.92 | Buy |
| 200-day EMA: | 88.08 | Buy |
Rapid7, Inc. Earnings Growth & RPD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.06 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
Rapid7, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||